Identification of H, K, and N-ras point mutations in Stage IB cervical carcinoma

被引:20
作者
Grendys, EC
Barnes, WA
Weitzel, J
Sparkowski, J
Schlegel, R
机构
[1] GEORGETOWN UNIV, MED CTR, DEPT PATHOL, WASHINGTON, DC 20007 USA
[2] GEORGETOWN UNIV, MED CTR, DIV GYNECOL ONCOL, WASHINGTON, DC 20007 USA
[3] CITY HOPE NATL MED CTR, CLIN CANC GENET PROGRAM, DUARTE, CA 91010 USA
关键词
D O I
10.1006/gyno.1997.4649
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The ras oncogenes, Harvey (H), Kirsten (K), and neuroblastoma (N), are a family of genes coding for a membrane-associated protein (p21) which possesses inherent guanine triphosphatase (GTPase) activity. Point mutagenesis at codons 12, 13, and 61 has been implicated in ras activation and subsequent cellular transformation. Given the epidemiologic relationship of HPV infection with cervical carcinoma and the tumorigenic interaction of HPV and mutated ras oncogenes, this study was undertaken to identify if mutated ras oncogenes were present in early invasive cervical carcinomas. Methods: A combination of polymerase chain reaction (PCR) and dot-blot hybridization was used to determine the frequency and types of ras point mutants occurring in cervical carcinoma. Thirty-three patients with early-stage cervical carcinoma were identified. DNA was extracted from archival tumor samples. ras genes were PCR amplified using flanking primers and hybridized with a series of labeled allele-specific oligonucleotides corresponding to wild-type forms of K-12,K-61, N-12,N-13,N-61, and H-12,H-61, as well as to all combinations of substitution mutations (7 wild-type, 45 mutants). Results: ras mutations were identified in 24.2% of specimens. The detected mutations in H, K, and N-ras all occurred at codon 61. This was not the result of PCR or hybridization artifact in that mutations were detected in position 12 and 13 in appropriate control samples. Conclusions: Mutant ras has been shown to convert HPV immortalized keratinocytes to the tumorigenic state. Our results indicate that a significant percentage (24.2%) of these early-stage cervical canters contain activated ras. Additional studies will be needed to evaluate whether codon 61 represents a characteristic ''hotspot'' of ras mutation in a subset of cervical carcinoma. (C) 1997 Academic Press.
引用
收藏
页码:343 / 347
页数:5
相关论文
共 31 条
[1]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[2]   GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD [J].
BAUER, HM ;
TING, Y ;
GREER, CE ;
CHAMBERS, JC ;
TASHIRO, CJ ;
CHIMERA, J ;
REINGOLD, A ;
MANOS, MM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04) :472-477
[3]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .10. THE RAS GENE FAMILY AND HUMAN CARCINOGENESIS [J].
BOS, JL .
MUTATION RESEARCH, 1988, 195 (03) :255-271
[4]   PROGNOSTIC-SIGNIFICANCE OF POLYMERASE CHAIN-REACTION DETECTED HUMAN PAPILLOMAVIRUS OF TUMORS AND LYMPH-NODES IN SURGICALLY TREATED STAGE-IB CERVICAL-CANCER [J].
BURNETT, AF ;
BARNES, WA ;
JOHNSON, JC ;
GRENDYS, E ;
WILLETT, GD ;
BARTER, JF ;
DONIGER, J .
GYNECOLOGIC ONCOLOGY, 1992, 47 (03) :343-347
[5]  
COOPER GM, 1990, ONCOGENES
[6]   BIOLOGICAL AND BIOCHEMICAL-PROPERTIES OF HUMAN RASH GENES MUTATED AT CODON-61 [J].
DER, CJ ;
FINKEL, T ;
COOPER, GM .
CELL, 1986, 44 (01) :167-176
[7]  
DIPAOLO JA, 1989, ONCOGENE, V4, P395
[8]   A PAPILLOMAVIRUS DNA FROM A CERVICAL-CARCINOMA AND ITS PREVALENCE IN CANCER BIOPSY SAMPLES FROM DIFFERENT GEOGRAPHIC REGIONS [J].
DURST, M ;
GISSMANN, L ;
IKENBERG, H ;
ZURHAUSEN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12) :3812-3815
[9]   EXPRESSION OF P21RAS IN FRESH PRIMARY AND METASTATIC HUMAN COLORECTAL TUMORS [J].
GALLICK, GE ;
KURZROCK, R ;
KLOETZER, WS ;
ARLINGHAUS, RB ;
GUTTERMAN, JU .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) :1795-1799
[10]   DETECTION OF HUMAN PAPILLOMAVIRUS GENOME AND ANALYSIS OF EXPRESSION OF C-MYC AND HA-RAS ONCOGENES IN INVASIVE CERVICAL CARCINOMAS [J].
IWASAKA, T ;
YOKOYAMA, M ;
OHUCHIDA, M ;
MATSUO, N ;
HARA, K ;
FUKUYAMA, K ;
HACHISUGA, T ;
FUKUDA, K ;
SUGIMORI, H .
GYNECOLOGIC ONCOLOGY, 1992, 46 (03) :298-303